<DOC>
	<DOCNO>NCT01921166</DOCNO>
	<brief_summary>The purpose study ( A ) determine follow novel approach improve live birth rate In-Vitro Fertilization ( IVF ) woman poor prognosis due diminish ovarian reserve : - ovarian stimulation medication effective woman diminish ovarian reserve adversely affect endometrium - oocyte retrieval vitrification - fertilization embryo transfer subsequent cycle control endometrial preparation B ) To determine optimal stimulation protocol woman diminish ovarian reserve incorporate oocyte vitrification Women eligible participate Carolinas Medical Center ( CMC ) Assisted Reproductive Therapy program extremely poor prognosis recruit prospective , randomize , open-label study determine novel approach improve live birth rate traditional IVF `` poor prognosis '' stimulation protocol . The novel approach incorporate one two protocol utilizing medication provide maximal ovarian stimulation temporary detrimental fertility-reducing effect endometrium . If ovarian stimulation adequate , oocyte retrieval perform viable oocyte vitrify ( store `` glass-like '' state liquid nitrogen ) . At late time , oocyte warm fertilization perform subsequent cycle , endometrium prepare . Key point include : - Randomization one two ovarian stimulation protocol show detrimental effect endometrium , therefore rarely use `` fresh '' IVF cycle - Oocyte vitrification consider investigational procedure American Society Reproductive Medicine ( ASRM ) , perform supervision IRB . With oocyte vitrification , ovarian stimulation oocyte retrieval `` unlinked '' embryo transfer , allow embryo transfer occur optimal environment - Endometrial preparation routine frozen embryo transfer</brief_summary>
	<brief_title>Maximal Stimulation Delayed Fertilization Diminished Ovarian Reserve : Randomized Pilot Study</brief_title>
	<detailed_description>Women eligible participate CMC Assisted Reproductive Therapy ( ART ) program extremely poor prognosis recruit prospective , randomize , open-label study determine novel approach improve live birth rate traditional IVF `` poor prognosis '' stimulation protocol . The novel approach incorporate one two protocol utilizing medication provide maximal ovarian stimulation temporary detrimental fertility-reducing effect endometrium . If ovarian stimulation adequate , oocyte retrieval perform viable oocyte vitrify ( store `` glass-like '' state liquid nitrogen ) . At late time , oocyte warm fertilization perform subsequent cycle , endometrium prepare . Key point include : - Randomization one two ovarian stimulation protocol show detrimental effect endometrium , therefore rarely use `` fresh '' IVF cycle - Oocyte vitrification consider investigational procedure American Society Reproductive Medicine ( ASRM ) , perform supervision IRB . With oocyte vitrification , ovarian stimulation oocyte retrieval `` unlinked '' embryo transfer , allow embryo transfer occur optimal environment - Endometrial preparation routine frozen embryo transfer Eligible patient randomize one two protocol : clomiphene + HMG leuprolide flare protocol . All subject must undergo pre-cycle IVF test per routine CMC ART program . In general , study comprise subject eligible IVF due extremely poor prognosis expect compromised ovarian stimulation ( see inclusion criterion ) . Subjects financially responsible treatment study . Randomized perform random number generator informed consent sign . Randomization point allow time order obtain required medication . Cycle start requirement ( performed cycle day 2 3 ) : - Basal Follicle Stimulating Hormone ( FSH ) 12 mIU/mL less AND - Basal estradiol 50 pg/mL less AND - Acceptable baseline ultrasound ( evidence condition IVF would contraindicate ) If patient meet start requirement , delay repeat cycle start test next IVF session . Group 1 : clomiphene + human menopausal gonadotropin Menopur Â® ( HMG ) - Clomiphene 100 mg cycle day 3-7 plus - HMG 300 unit daily begin cycle day 3 continue day HCG ( Ovidrel ) administration Group 2 : leuprolide flare + HMG - leuprolide acetate 0.5 mg twice daily begin cycle day 3 continue day HCG ( Ovidrel ) administration - HMG 300 unit daily begin cycle day 3 continue day HCG ( Ovidrel ) administration Both group : - Follow-up ultrasound , estradiol cycle day 8 . Cancel cycle estradiol &lt; 200 pg/mL . If estradiol 200 pg/mL high , make HMG dose adjustment schedule follow-up estradiol ultrasound visit per routine IVF protocol . - Administer Ovidrel 500 mg 2nd large follicle reach mean diameter 18mm . Cancel cycle &lt; 3 follicle 10mm large recruit spontaneous ovulation occur . - Retrieval : per standard IVF routine - Vitrification : viable oocyte vitrify day oocyte retrieval . - Remainder stimulation cycle : additional medication - Stimulation retrieval cycle may repeat patient request &lt; 5 oocyte vitrify store additional oocyte transfer cycle . Transfer cycle : - Programmed frozen embryo transfer protocol per ART program routine : precycle treatment oral contraceptive ( OCP ) , leuprolide administration OCP , OCP withdrawal bleeding , estrogen prim endometrium , ultrasound assessment endometrium 12-14 day , addition daily progesterone endometrial thickness 7mm great , oocyte warming/fertilization/transfer schedule . - Oocyte warm intracytoplasmic sperm injection ( ICSI ) : oocyte warm 2nd day progesterone administration ( example , progesterone start Monday , oocytes warm Tuesday ) . Semen sample collect day warm prepared per IVF routine ICSI . Mature viable oocyte undergo ICSI . Per ART laboratory routine , oocyte assess fertilization follow day . If embryos available transfer , embryo transfer procedure perform accord standard CMC ART program guideline 6-8 cell blastocyst stage . If available , excess embryo may cryopreserved , patient ' request , per CMC ART Program routine . Follow-up hormonal therapy , pregnancy test ( ) , ultrasound study perform per CMC ART program protocol . Vitrified oocytes discard kept storage accord term oocyte storage agreement . Crossover : If patient fail conceive , may elect cross-over opposite treatment group</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<criteria>Basal FSH 17 IU/mL ( high ever ) Basal FSH 1517 ( high ever ) fail EFORT test Age &gt; 43 time expect retrieval Failure conceive prior `` poor prognosis '' IVF stimulation protocol ( microdose leuprolide flare GnRH antagonist cycle ) administer evidence diminish ovarian reserve Failure conceive 3 IVF cycle CMC Contraindications IVF Contraindication pregnancy Allergy contraindication medication use IVF embryo transfer Use gestational carrier Uncorrected untreatable uterine infertility Smoking substance abuse within 3 month initiate stimulation IVF</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>infertility</keyword>
	<keyword>diminish ovarian reserve</keyword>
	<keyword>fertilization vitro</keyword>
	<keyword>ovulation inducion</keyword>
	<keyword>vitrification</keyword>
</DOC>